Southern Clinical Trials Group

Southern Clinical Trials Group (SCTG) was established in 2011 to provide clinical governance, business development and administrative oversight to the trial sites.  

SCTG now has 6 sites, 1 in Christchurch, 4 in Auckland and a further site is currently being established in Nelson. All sites are based in or around primary care and have access to large General Practice databases. All SCT sites have experienced Principal Investigators and Study Coordinators. 

SCTG sites have completed a wide range of phase 1B – 4 clinical trials. Recent trials include vaccine studies (influenza, hepatitis B, pneumococcal and HPV), lipid lowering, diabetes, osteoarthritis, immune response, migraine, soft tissue injuries, COPD, atopic dermatitis, asthma, rapid antigen devices, urticaria, aging, gout, endometriosis, cardiovascular outcomes, pain, depression and acute influenza. 

SCTG sites are frequently amongst the highest study recruiters in the Asia Pacific region. All SCTG sites use a common CTMS and electronic source documents. 

SCTG is proud to be part of the large Australian/New Zealand network Pacific Clinical Research Network. 

The head office is at Forte 2, 132 Peterborough St, Christchurch, New Zealand.

For more information: www.sctrials.co.nz

Owner, Principal Investigator

Southern Clinical Trials Group

Owner, Director Clinical Trials

Southern Clinical Trials Group

Tania De la Cruz

Office Administrator

Southern Clinical Trials Group

Southern Clinical Trials Group Research Sites

29 Birkenhead Avenue, Level 1 Birkenhead, Auckland 0626, New Zealand
1 McCrae Way, Level 1, New Lynn, Auckland 0600, New Zealand
94 Remuera Road, Remuera Auckland 1050, New Zealand
175 Cavendish Drive, Manukau Auckland 2104, New Zealand

Forte 2, Level 2, 132 Peterborough Street
Christchurch 8013, New Zealand